Kronos Bio
KRON
$1.04
Share price
-3.70%
Change (1 day)
-36.59%
Change (1 year)
Categories
Kronos Bio (KRON) - Cash on Hand
Cash on Hand as of March 2024 : $0.15 B
According to Kronos Bio's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kronos Bio - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.23 B | -29.84% |
| 2021-12-31 | $0.33 B | -17.81% |
| 2020-12-31 | $0.41 B | 348.08% |
| 2019-12-31 | $92.18 M | 801.47% |
| 2018-12-31 | $10.22 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 108.43% | 🇺🇸 USA |